StockWatch
·

Bajaj Consumer Care Ltd

BSE: 533229

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
335.29
-2.3%+32.6%
Expenditure
248.13
-3.2%+23.7%
Net Profit
70.53
+0.5%+64.0%
OPM %
25.30%
+0.61pp+5.44pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0096.07192.15288.22384.30Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Growth Accelerates, But Margins Squeezed—Q3 Pricing Will Decide

pricing power · margin compression · ADHO reinvigoration

Result verdictFollow-upQ2 FY2721 Oct 20266 minFMCG

Strong growth, margin pressure yet contained; pricing power tested

distribution expansion · pricing actions · Almond Drops reinvigoration

TranscriptDeep diveQ2 FY2721 Oct 20266 minFMCG

Bajaj Consumer Care Q2 FY27: PAT +66% YoY to ₹70 Cr as margins expand to 24.7%

fmcg · personal care · margin expansion

ResultsQ2 FY2714 Oct 20263 minFMCG
Latest
Board Meeting14 Oct, 5:50 pm

Bajaj Consumer Care Q2 FY27: PAT +66% YoY to ₹70 Cr as margins expand to 24.7%

Bajaj Consumer Care's consolidated PAT rose 65.9% YoY to ₹70.15 Cr in Q2 FY27 (quarter ended Sep 30, 2026), well ahead of the 25.5% YoY rise in revenue from operations to ₹332.83 Cr (from ₹265.27 Cr) — net margin expanded to 21.1% from 15.5% a year ago. Sequentially both lines pulled back modestly from Q1 FY27's pace (revenue -2.6% QoQ from ₹341.57 Cr, PAT -0.8% QoQ from ₹70.75 Cr); this reads as normalization after Q1's unusually strong 28% YoY print rather than a seasonality effect, and management had itself flagged a near-term slowdown. Consolidated basic EPS was ₹5.37 versus ₹3.24 a year ago and ₹5.42 in Q1. No exceptional items or minority-interest adjustments appear in either statement, so the comparisons are on a clean basis; standalone PAT of ₹70.53 Cr is marginally higher than consolidated, an immaterial (<1%) divergence from one loss-making subsidiary. Gross margin compressed to roughly 59.9% from ~61.8% in Q1 — exactly the raw-material-cost pressure (linked to West Asia volatility) management guided for on the July concall. Despite that drag, the operating (EBITDA) margin still expanded to ~24.7% from 18.0% a year ago and 24.4% in Q1, landing inside the "low-to-mid-20s" band management said it was targeting; advertising-spend discipline and fixed-cost optimization offset the gross-margin squeeze, so the quarter reads as guidance met. Against our pre-result preview (Q2 revenue ~₹365–380 Cr, EBITDA margin 22–24%, PAT ~₹55–65 Cr), the company missed on revenue but beat on margin and profit, with PAT coming in well above the flagged range. Street consensus heading in had priced FY27 revenue growth of 19% and profit growth of 41% (unanimous BUY across 8 analysts, PT ₹695–696 vs ₹489 then); this quarter's 25.5%/65.9% YoY prints run ahead of that full-year math, though one quarter doesn't confirm the full-year trajectory given Q1's even stronger comp. No management press release accompanies this filing, so there is no fresh managerial commentary on the quarter beyond the standard board-meeting outcome letter. Alongside the results, the board accepted independent director K.S. Narayanan's resignation (effective close of business Oct 14, cited personal/medical reasons) and appointed Jitendra Mahajan — a three-decade FMCG veteran from Diageo, Marico and Britannia — as his replacement for a five-year term. This follows an August senior-management change and a September HDFC Mutual Fund stake reduction (cut 2.88 points to 4.43%); none of these move this quarter's P&L directly but add governance-watch context alongside the numbers.

14 Oct 2026, 05:50 pm

Corporate Events

Board MeetingBAJAJCON
2026
14Oct

Board Meeting

The meeting of the Board of Directors of the Company is sche…

BSE Filing ↗
Board MeetingBAJAJCON
2026
5Aug

Board Meeting

The Twentieth (20th) Annual General Meeting (“AGM”) of the C…

BSE Filing ↗
Board MeetingBAJAJCON
2026
13Jul

Board Meeting

The meeting of the Board of Directors of the Company is sche…

BSE Filing ↗
Board MeetingBAJAJCON
2026
17Apr

Board Meeting

To consider and approve the audited financial results (stand…

BSE Filing ↗
Board MeetingBAJAJCON
2026
21Jan

Board Meeting

Consider and approve Notice, Approve Unaudited Financial Res…

BSE Filing ↗
Board MeetingBAJAJCON
2025
10Nov

Board Meeting

Consider and approve Notice, approve the Unaudited Financial…

BSE Filing ↗
Board MeetingBAJAJCON
2025
11Aug

Board Meeting

Consider and approve Notice is hereby given .... ended June …

BSE Filing ↗
Board MeetingBAJAJCON
2025
24Jul

Board Meeting

Consider and approve proposal for buyback of fully paid-up e…

BSE Filing ↗
Board MeetingBAJAJCON
2025
12Feb

Board Meeting

Consider and approve Notice, Approve Unaudited Financial Res…

BSE Filing ↗
Board MeetingBAJAJCON
2024
8May

Board Meeting

consideration and approval of Audited Financial Results (Sta…

BSE Filing ↗
DividendBAJAJCON
2024
17Feb

₹3 / share

BSE Filing ↗
Board MeetingBAJAJCON
2024
5Feb

Board Meeting

Consideration and approval of Unaudited Financial Results (S…

BSE Filing ↗
Board MeetingBAJAJCON
2023
9Nov

Board Meeting

Approval of Unaudited Financial Results (Standalone and Cons…

BSE Filing ↗
Board MeetingBAJAJCON
2023
9Aug

Board Meeting

Approval of Unaudited Financial Results (Standalone and Cons…

BSE Filing ↗